J Clin Invest 1998
The study, with its rigorous clinical design, confirmed that the intervention group exhibited significant improvements compared to the placebo group in menstrual cycle regularity (p=0.023), total testosterone levels (p=0.043), waist circumference (p=0.030), and quality of life (p=0.034), with no reported adverse effects (108)
Preclinical Research Preclinical studies with retatrutide have consistently demonstrated superior metabolic effects compared to GLP-1 monoagonists across obesity, diabetes, and NASH rodent models providing the mechanistic foundation for its subsequent clinical development
Goin-Kochel RP, Scaglia F, Schaaf CP, Berry LN, Dang D, Nowel KP, Laakman AL, Dowell LR, Minard CG, Loh A, Beaudet AL
Less volume, higher standards One of the clearest behavioural changes tied to GLP-1 adoption is that people are simply eating less
Conveniently sized, you can easily take them regularly before and after your workouts with a small sip of water